SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Orchid Pharma

BSE: 524372|NSE: ORCHIDPHAR|ISIN: INE191A01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 25, 16:00
41.75
-0.05 (-0.12%)
VOLUME 273,029
LIVE
NSE
Jul 25, 15:57
41.85
0.25 (0.6%)
VOLUME 925,836
Announcements on Orchid Pharma

22nd-Jul-2016 20:44Source: BSE

Orchid Pharma- Shareholding for the Period Ended June 30, 2016

Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly

19th-Jul-2016 11:25Source: BSE

Orchid Pharma- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016

Orchid Pharma Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Ob...

8th-Jun-2016 11:59Source: BSE

Orchid Pharma- Resignation of Non-executive & Non-independent Director

Orchid Pharma Ltd has informed BSE that the Company have received a letter dated May 31, 2016 from Shri S. Krishnan, non-executive & non-independent Director wherein he has resigned from the Board and...

8th-Jun-2016 11:44Source: NSE

Orchid Pharma Limited

Orchid Pharma Limited has informed the Exchange that the Company have received a letter dated May 31, 2016 from Shri S Krishnan, non-executive & non-independent Director wherein he has resigned from t...

18th-May-2016 13:10Source: NSE

Orchid Pharma Limited

Orchid Pharma Limited has informed the Exchange that the SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in the securities of the Company shall remain closed for all ...

18th-May-2016 11:17Source: BSE

Orchid Pharma- Board Meeting Intimation for Results & Closure of Trading Window

Orchid Pharma Ltd has informed BSE that a meeting of the Board of Directors is proposed to be held on May 27, 2016, to approve the Audited financial results of the Company for the period from April 01...

11th-Apr-2016 11:44Source: BSE

Orchid Pharma- Updates

Orchid Pharma Ltd has informed BSE that Orchid received the Establishment inspection report (EIR) from USFDA based on the successful inspection closure for the API manufacturing facility located at Al...

11th-Apr-2016 11:27Source: NSE

Orchid Pharma Limited

Orchid Pharma Limited has informed the Exchange that the Company received the Establishment inspection report (EIR) from USFDA based on the successful inspection closure for the API manufacturing faci...

17th-Mar-2016 13:48Source: BSE

Orchid Pharma- Orchid receives final USFDA nod for Rasagiline generic formulation

Orchid Pharma Ltd has informed BSE regarding a Press Release dated March 17, 2016 titled "Orchid receives final USFDA nod for Rasagiline generic formulation".

17th-Mar-2016 13:23Source: NSE

Orchid Pharma Limited

Orchid Pharma Limited has informed the Exchange regarding a press release dated March 17, 2016 titled "Orchid receives final USFDA nod for Rasagiline generic formulation".

1 2 3 4 5 Next >>
Quick Links for Orchid Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.